Aetna and Humana will sell certain Medicare Advantage assets to Molina Healthcare as the insurers prepare to defend their merger against a U.S. Justice Department lawsuit.
Additionally, Aetna has said its worsening performance on public exchanges has forced the company to rethink its 2017 expansion plans and evaluate all of its individual plans in the 15 states where it currently sells Obamacare, company chairman Mark Bertolini said. Humana has already said it is pulling off most ACA exchanges for next year, and rival UnitedHealth Group, too, is scaling back to three states, which will leave Anthem and Blue Cross and Blue Shield plans as the main Obamacare providers across the country.
“We are undertaking a complete evaluation of our exchange footprint,” Bertolini said.
Full Content: Forbes
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Dior Commits €2 Million to Labor Initiatives in Italian Antitrust Settlement
May 21, 2025 by
CPI
Indonesia’s Antitrust Watchdog Probes Potential Risks of Grab-GoTo Merger
May 21, 2025 by
CPI
Live Nation Taps Trump Ally Richard Grenell Amid DOJ Lawsuit
May 21, 2025 by
CPI
Luxair Files EU Court Challenge Over Lufthansa-ITA Merger Approval
May 21, 2025 by
CPI
Tennis Governing Bodies Move to Dismiss PTPA Antitrust Lawsuit
May 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros